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Corticotropin-Releasing Hormone Inhibits Nuclear Factor-jB
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Treatment of human HaCaT keratinocytes with corti-
cotropin-releasing hormone modulates cell prolifera-
tion and expression of in£ammation markers. In this
study we report that corticotropin-releasing hormone
also inhibits nuclear factor-jB binding and transcrip-
tional activity. Incubating cells in the absence of growth
factors increased nuclear factor-jB activity; this e¡ect
was signi¢cantly attenuated by corticotropin-releasing
hormone. Speci¢cally, corticotropin-releasing hormone
downregulated p50/p50 and p50/p65 dimers of nuclear
factor-jB, diminished jB-driven CAT reporter gene
activity and inhibited IjB-b degradation. Moreover,
corticotropin-releasing hormone inhibited the trans-
cription of the nuclear factor-jB responsive genes,
interleukin-2 and heat shock protein 90. Key words: cor-
ticotropin-releasing hormone/epidermis/keratinocyte/nuclear
factor-jB/stress. J Invest Dermatol 121:1496 ^1499, 2003
I
t is generally accepted that corticotropin-releasing hormone
(CRH), a 41 amino acid long peptide, acts as the main co-
ordinator of the central response to stress (Chrousos and
Gold, 1992). CRH is also produced locally in peripheral
organs including the skin to regulate local homeostasis
(Slominski et al, 2000b, 2001).
The outermost layer of the skin, the epidermis, plays a crucial
part in maintaining internal homeostasis, and serves as a barrier
between the environment and the internal milieu. Keratinocytes
regulate the activity of the skin’s immune system and protect the
skin from noxious stressors (Slominski et al, 2000a, 2001). HaCaT
keratinocytes both produce CRH and express functional CRH-
R1-a receptor (Pisarchik and Slominski, 2001; Quevedo et al,
2001; Zbytek et al, 2002). CRH signal transduction is coupled to
adenylate cyclase, phospholipase C, or to voltage-gated calcium
channels (Owens and Nemero¡, 1991; Slominski et al, 2001).
CRH inhibits proliferation of keratinocytes and modi¢es expres-
sion of adhesion molecules and cytokine secretion (Slominski et
al, 2000a, 2001; Quevedo et al, 2001; Zbytek et al, 2002). In this
context, the epidermis may possess a high sensory capability for
noxious stimuli through a local stress response pathway involving
the CRH/CRH-R signaling system (Slominski et al, 2000b,
2001).
Nuclear factor (NF)-kB is an inducible and ubiquitously ex-
pressed transcription factor (Yang et al, 2000; Li and Verma,
2002). Active NF-kB complexes are dimers of various combina-
tions of the Rel/NF-kB family of polypeptides, which includes
p50, p52, v-Rel, c-Rel, RelA, and RelB. NF-kB is sequestered
in cytoplasm by the binding of NF-kB inhibitor proteins, which
block the nuclear localization sequences present in NF-kB.
NF-kB-inducing stimuli promote dissociation of the inactive
NF-kB complexes via the serine phosphorylation and degrada-
tion of IkB. These events lead to unmasking of nuclear localiza-
tion sequences, thereby allowing NF-kB to enter the nucleus and
bind to kB-regulatory elements.
HaCaT cells have higher constitutive levels of NF-kB activity
than normal keratinocytes (Quin et al, 1999), which may be mod-
i¢ed by ultraviolet radiation and L-ascorbic acid (Saliou et al,
1999; Tebbe et al, 2001). As NF-kB is a recognized co-ordinator
of the cellular response to stress and CRH is a critical element
in the epidermal response to stress, we tested whether CRH sig-
naling was coupled to the NF-kB pathway in HaCaT cells.
MATERIALS ANDMETHODS
Cell culture HaCaT keratinocytes were cultured in a Dulbecco minimal
Eagle’s medium, supplemented with 10% fetal calf serum and 1%
antibiotic/anti-mycotic mixture (Gibco, Invitrogen Life Technologies
Carlsbad, California) as previously described (Slominski et al, 2000a).
Cells were seeded at density 10,000 cells per cm2, grown for 48 h until
70% con£uency and then treated with CRH (Sigma, St. Louis, MO) as
indicated in Results.
Electrophoretic mobility shift assay Nuclei extracts were prepared as
previously described (Yang et al, 2000) and were used for electrophoresis
mobility shift assay. NF-kB oligonucleotide probe (Promega, Madison,
Wisconsin) was end-labeled with [g-32P]deoxyadenosine triphosphate
using T4 polynucleotide kinase and incubated with 5 mg of nuclear
extract. The protein-DNA complexes were separated on 5% poly-
acrylamide gel. For supershift assays nuclear extracts were incubated with
p50, p65, c-rel, or p52 antibodies (Santa Cruz Biotechnology Inc., Santa
Cruz, California). To determine binding speci¢ty, a 50 excess of
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unlabeled oligonucleotide was used. Radioactivity was quantitated with
Packard Cyclone phosphorimager, and analyzed with Optiquantt (Perkin
Elmer Life Sciences Inc., Boston, Massachusetts) and Adobe Photoshop
(San Jose, California) software.
Western blot analysis of IjB-a and IjB-b levels HaCaT cells were
lyzed in RIPA bu¡er and clari¢ed by centrifugation (10,000 g, 10 min).
Cell lysates (10 mg) were separated on 12% sodium dodecyl sulfate^
polyacrylamide gel electrophoresis gel and transferred to the PVDF
membrane. After blocking with Tris-bu¡ered saline, Triton-X 0.05% and
5% milk, the membranes were incubated with rabbit anti-human IkB-a
or IkB-b a⁄nity-puri¢ed polyclonal IgG (1:200, Santa Cruz Bio-
technology Inc.), followed by incubation with horseradish peroxidase
conjugated goat anti-rabbit IgG (1:10,000 dilution). IkB-a and IkB-b were
visualized by with Supersignal West Pico Chemiluminescent Substrate
(Pierce, Rockford, Illinois). The membranes were stripped and reprobed
with antibody against actin (1:500, Santa Cruz Biotechnology Inc.). The
chemiluminescent signal was recorded using Fluor-S MultiImager and
analyzed with Quantity One software (Bio-Rad Laboratories, Hercules,
California).
Reporter gene assay Keratinocytes were transfected using Lipo-
fectamine Plus reagent (Gibco, Invitrogen Life Technologies) with either
the pUX-CAT promoterless chloramphenicol acetyltransferase construct
or pUX-CAT 3XHLAkB construct, which contains three tandemly
repeated copies of NF-kB site from human leukocyte antigen B7 gene
(provided by Dr J. Vilcek, New York University Medical Center). CAT
activity was assayed by thin-layer chromatography and quantitated by
phosphorimaging using Optiquant software (Packard Cyclone, Perkin
Elmer Life Sciences Inc.).
Oligonucleotide array Total RNAwas extracted using Trizol isolation
kit (Gibco-BRL, Gaithersburg, Maryland). Human pathway ¢nder-1
and human NF-kB-1 pathway GEArrays (Superarray, Inc., Bethesda,
Maryland) were performed according to the manufacturer’s protocol.
Abundance of transcripts was quantitated by phosphorimaging as described
above and normalized to glyceraldehyde 3-phosphate dehydrogenase
expression.
Heat shock protein (HSP)-90 and interleukin (IL)-2 northern
blot Twenty micrograms of total RNA was separated on 1% agarose
gel, transferred to the nylon membrane and then ultraviolet cross-linked.
HSP-90 (accession number X15183; 367 bp) was prepared using DNA
isolated from the plasmid of the Escherichia coli clone IMAGE:5539895. The
sequences of primers were as follows: sense 50 -GGTAGCTAACTCAG-
CCTTTGTGG, anti-sense: 50 -TGAGTTGTCTCTTAGGGCTTGAGC.
Polymerase chain reaction conditions: 941C 30, 30 cycles (941C 450 0,
54.71C 450, 721C 10), 721C 40. Amount of polymerase chain reaction
reagents as described in manufacturer’s protocol ( JumpStartt AccuTaqt,
Sigma, St Louis, Missouri). IL-2 (accession number U25676; 468 bp) was
prepared by polymerase chain reaction using complementary DNA
isolated from stimulated lymphocytes. Primers sequences were as follows:
sense: 50 -ACATTTAAGTTTTACATGCCCAAG, anti-sense: 50 -GTAAA-
CCATTTTAGAGCCCCTAG. Polymerase chain reaction conditions and
solution as above except elongation step: 52.11C 45 s. Denatured
complementary DNA probes (0.2 mg) were labeled by random priming
using 50 mCi [a-32P]deoxyadenosine triphosphate (NEN Life Science
Products, Boston, Massachusetts), 5 mg random hexamers, 3 mL of 0.5 M
solution of deoxynucleotide triphosphates, 5 U Klenow fragment
(exonuclease^, MBI Fermentas,Vilnius, Lithuania), 5Klenow bu¡er and
water to a total volume of 50 mL. The membrane was hybridized with
radioactive probe in standard conditions and visualized with Kodak
X-OMAT ¢lm in 701C for 24 h.
Statistical analysis Data are presented as mean7SEM, and was
analyzed using one-way analysis of variance and appropriate post-hoc test
using Prism 3.00 software (GraphPad Software, San Diego, California).
Signi¢cant di¡erences are denoted by p values less than 0.005.
RESULTS
NF-jb binding activity in HaCaT HaCaT cells were
incubated in serum-free Dulbecco minimal Eagle’s medium
containing CRH (0^100 nM) for 0, 15, 30, or 60 min. Nuclear
extracts were prepared and analyzed for NF-kB activation by
electrophoresis mobility shift assay and supershift assays (Fig 1).
Serum withdrawal increased formation of speci¢c NF-kB
complexes de¢ned by supershift assays as p50/p50 and p50/p65.
In contrast, CRH treatment (100 nM) signi¢cantly decreased
formation of p50/p50 and p50/p65 complexes after 15 and 30
min as compared with cells not treated with CRH (Fig 1). The
e¡ects of serum withdrawal and CRH on NF-kB disappeared
after 60 min.
Western blot analysis of IjB-a and IjB-b levels Inhibitory
IkB proteins sequester NF-kB in the cytoplasm and tightly
control the activity of NF-kB. To determine whether NF-kB
activation by CRH re£ects IkB degradation, IkB-a and IkB-b
levels were determined by immunoblotting of cell lysates
prepared at various times after serum withdrawal with or
without CRH addition. As shown in Fig 2, the levels of
cellular IkB-a did not change upon serum withdrawal. In
contrast, IkB-b levels were reduced by 63% upon serum
withdrawal, and treatment with CRH attenuated this e¡ect.
These results indicated that CRH attenuated IkB-b degradation
induced by serum withdrawal.
CAT assay CRH-mediated attenuation of serum withdrawal-
induced NF-kB signal was further con¢rmed by CAT gene
Figure1. CRH treatment attenuates NF-jB DNA binding activity
induced upon serum withdrawal from HaCaT keratinocytes. Nucle-
ar extracts were prepared from HaCaT cells treated with serum-free med-
ium with 100 nM CRH for 0, 15, 30, and 60 min and subjected to
electrophoresis mobility shift assay; 0 min represents the NF-kB signal
from cells not subjected to serum withdrawal. The presence of speci¢c
Rel proteins in DNA complexes in CRH-treated cells (100 nM, 15 min)
was detected by supershift assay using p50 and p65 anti-sera. Cold repre-
sents extract incubated with a 50-fold excess of unlabeled kB probe.
Results are representative of three separate experiments.
Figure 2. CRH diminishes IjB-b degradation. HaCaT cells grown in
medium supplemented with fetal calf serum (0) were shifted to serum-free
medium without () or with 100 nM CRH (þ ). Total cell lysates were
analyzed by immunoblotting. Results are representative of six separate
experiments.
CRH INHIBITS NF-kB IN KERATINOCYTES 1497VOL. 121, NO. 6 DECEMBER 2003
reporter assay. Extracts were prepared from cells containing kB-
driven vector that were treated for 30 and 60 min in serum-free
medium without or with 100 nM CRH. As shown in Fig 3
serum withdrawal resulted in a 6-fold induction of kB-driven
CAT activity as compared with the cells transfected with a
promoterless CAT construct. In contrast, CRH attenuated the
increased activity by 74% (down to 1.6-fold as compared with
the cells transfected with a promoterless CAT construct).
Analysis of NF-jB dependent genes Using commercially
available oligonucleotide arrays we also tested the e¡ect of CRH
on the transcription of genes associated with NF-kB signaling
pathways in cells subjected to serum withdrawal. Genes coding
NF-kB, IkB kinase (IKK)-a, IKK-b, IKK-g, IkB-a, c-rel,
cellular myelocytomatosis oncogene, and NF-kB responsive
genes (human endothelial leukocyte adhesion molecule, granu-
locyte colony stimulating factor, granulocyte-macrophage
colony stimulating factor, intercellular adhesion molecule 1,
interferon regulatory factor 1, small inducible cytokine A2, IL-6,
IL-8, inducible nitric oxide synthase; P-selectin, tumor necrosis
factor-a and -b, tumor necrosis factor-a-induced protein 1;
vascular cell adhesion molecule) were not a¡ected by CRH.
Exposure of cells to CRH (100 nM), however, signi¢cantly
decreased transcription of IL-2 and HSP-90 genes in compa-
rison with cells at 30 min after serum withdrawal (data not
shown). To determine by an independent means our prelimi-
nary results with oligonucleotide arrays, we examined whether
CRH a¡ected IL-2 and HSP-90 mRNA levels by northern
blot. As shown in Fig 4, at 30 min after serum withdrawal
there was high expression of IL-2 and HSP-90 mRNA.
Treatment with CRH markedly reduced IL-2 and HSP-90
mRNA expression (70% and 99% reduction, respectively). The
observed e¡ect of CRH was transient and by 2 h after CRH
treatment there was no detectable e¡ect on IL-2 or HSP-90
mRNA levels.
DISCUSSION
In previous studies we have documented that human keratino-
cytes express functional CRH receptors. Activation of these
receptors results in increased cyclic adenosine monophosphate
production, cytosolic calcium £ux, inhibition of proliferation,
modi¢cation of cell surface expression of adhesion molecules
and production of cytokines (Slominski et al, 2000a, b, 2001;
Quevedo et al, 2001; Zbytek et al, 2002). In addition, CRH treat-
ment of HaCaT cells inhibited lipopolysaccharide (LPS)-en-
hanced IL-6 production (Zbytek et al, 2002) and decreased
interferon-g induced expression of intercellular adhesion mole-
cule-1 (unpublished observations).
In this study using immortalized HaCaT keratinocytes we have
shown that CRH can inhibit NF-kB binding and transcriptional
activity. Choice of 100 nM concentration was based on prelimin-
ary electrophoresis mobility shift assay experiments, which have
shown that CRH at this concentration exerts the maximal e¡ect
on serum deprivation-induced NF-kB activation. E¡ects of
CRH on cyclic adenosine monophosphate activation in HaCaT
cells also was maximal at 100 nM (Slominski et al, 2000a). CRH
levels may reach relatively high levels locally (Karalis et al, 1991). A
100 nM concentration is used in comparable models, such as in
the model of regulation of IL-1a production in the monocyte
(Pereda et al, 1995) or the model of suppression of NF-kB activity
in mouse pituitary corticotropic AtT20 cells (Lezoualc’h et al,
2000). NF-kB is important in several stress-related pathways. Sti-
muli acting through di¡erent receptor systems converge on the
NF-kB pathway. On the other hand NF-kB a¡ects di¡erent
genes depending on the cell type or presence of external stimuli
(Yang et al, 2000; Li andVerma, 2002). In our model, withdrawal
of serum for 15 and 30 min enhances a constitutively activated
NF-kB pathway that is in turn attenuated by CRH.
The activation of NF-kB involves selectively IkB-b degrada-
tion. Kinetics of NF-kB activation and IkB degradation vary
among stimulating agents and cell types (Li and Verma, 2002).
IkB-b degradation is triggered by IL-1, nerve growth factor,
LPS, as well as upon serum withdrawal (Thompson et al, 1995;
Cosgaya and Shooter, 2001). IkB degradation is characteristic for
biphasic NF-kB activation. Degradation of IkB-b is observed
shortly after application of the stimulus as well as after prolonged
incubation (Thompson et al, 1995). Phosphorylation of IkB pro-
teins that precedes their degradation is mediated by IkB kinases.
Multiple signaling pathways converge on the IKK complex and
result in its activation. For example, the atypical protein kinase
Cz may be involved in this process (Li and Verma, 2002). Protein
kinase Cz is expression in the keratinocytes and activated by
phospholipids (E¢mova et al, 2002). CRH receptor signaling re-
sults in phospholipase C activation (Owens and Nemero¡, 1991).
Elucidation of the pathway by which CRH is linked to IkB-b
will require further studies.
CRH through its action on NF-kB, an integrator of cellular
response to stress, counteracts acute stress to stabilize cellular
homeostasis. In support of this hypothesis we have found that
CRH altered the pattern of NF-kB-dependent gene expression.
We found that CRH decreased kB-driven reporter gene tran-
scription and selectively downregulated the NF-kB-dependent
genes IL-2 and HSP-90. IL-2 and HSP-90 are produced constitu-
Figure 3. CRH e¡ects on NF-jB-dependent reporter construct. Ha-
CaT cells were transiently transfected with pUX-CAT (EV) or pUX-CAT
3XHLAkB (NF-kB) vector, incubated for 30 min in serum-free media
without (control) or with 100 nM CRH, and assayed for CAT activity.
The data represent the mean7SEM (n¼ 4) after subtraction of back-
ground, related to empty vector activity (¼1).
Figure 4. CRH inhibits transcription of IL-2 and HSP-90 mRNA.
HaCaT keratinocytes were treated for 30 min with serum-free medium
without (control) or with 100 nM CRH, and total RNA was isolated.
Gene expression was estimated by northern blot technique using HSP-90
and IL-2 radioactive probes (upper panel). Ethidium bromide stain of total
RNA indicates equal loading of the samples into the gel.
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tively in several immortalized cell lines, suggesting their positive
role in cell proliferation (Stepanova et al, 1996; Reichert et al,
2000). Speci¢cally, IL-2 mediates cell cycle progression through
downregulation of cyclin-dependent kinase inhibitors 1A and 1B
(Reichert et al, 2000). HSP-90 together with cell division cyclin
37 stabilizes cyclin-dependent kinase 4 and the cyclin D complex
that mediates passage through a cell cycle restriction point (Stepa-
nova et al, 1996). Therefore, inhibition of IL-2 and HSP-90 genes
expression by CRH may be a part of a signaling cascade induced
by CRH that results in inhibition of HaCaT cell proliferation
(Slominski et al, 2000a, 2001). HSP-90 is also involved in LPS sig-
nal transduction (Trianta¢lou et al, 2001). Thus, it is also possible
that modulation of HSP-90 expression may be involved in
CRH-induced di¡erential regulation of IL-6 production depen-
dent on the presence of LPS (Trianta¢lou et al, 2001; Zbytek et al,
2002). Nevertheless, we have not found that short-term serum
withdrawal and CRH a¡ect mRNA levels of in£ammatory
mediators in HaCaT keratinocytes. Further studies are essential
to elucidate the in£uence of CRH on stress-related gene expres-
sion in the keratinocyte.
In summary, we have demonstrated that CRH can inhibit the
stress-related NF-kB pathway in immortalized human epidermal
keratinocytes.
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